2141-V11 - Memorial Sloan-Kettering Cancer Center, Rockefeller University
5-fluorouracil - Generic mfg.
Opdivo (nivolumab) - Ono Pharmaceutical, BMS
A Study of 2141-V11 in People With Esophageal, Gastric, or Gastroesophageal Junction Adenocarcinoma (clinicaltrials.gov) - Sep 15, 2026 - P1/2 | N=30 | Recruiting | Sponsor: Memorial Sloan Kettering Cancer Center 
New P1/2 trial • Esophageal Adenocarcinoma • Esophageal Cancer • Gastric Cancer • Gastroesophageal Cancer • Gastroesophageal Junction Adenocarcinoma • Oncology • Solid Tumor
http://clinicaltrials.gov/ct2/show/NCT07818018
 
Sep 15, 2026
 
Prev Next